# Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease

> **NCT00815282** · PHASE4 · COMPLETED · sponsor: **N.M. Wulffraat** · enrollment: 135 (actual)

## Conditions studied

- Juvenile Idiopathic Arthritis
- Systemic Lupus Erythematosus
- Juvenile Dermatomyositis

## Interventions

- **OTHER:** Human papilloma virus vaccine (cervarix)

## Key facts

- **NCT ID:** NCT00815282
- **Lead sponsor:** N.M. Wulffraat
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2017-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00815282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00815282, "Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00815282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*